Jaguar Health (JAGX) Net Income towards Common Stockholders (2016 - 2025)
Jaguar Health (JAGX) has disclosed Net Income towards Common Stockholders for 11 consecutive years, with -$23.2 million as the latest value for Q4 2025.
- Quarterly Net Income towards Common Stockholders fell 126.63% to -$23.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$54.0 million through Dec 2025, down 38.55% year-over-year, with the annual reading at -$53.6 million for FY2025, 39.18% down from the prior year.
- Net Income towards Common Stockholders for Q4 2025 was -$23.2 million at Jaguar Health, down from -$9.6 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was -$7.6 million in Q4 2022, with the low at -$23.2 million in Q4 2025.
- Average Net Income towards Common Stockholders over 5 years is -$11.7 million, with a median of -$10.6 million recorded in 2025.
- The sharpest move saw Net Income towards Common Stockholders surged 47.03% in 2022, then plummeted 126.63% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$14.3 million in 2021, then skyrocketed by 47.03% to -$7.6 million in 2022, then decreased by 20.96% to -$9.2 million in 2023, then decreased by 11.6% to -$10.2 million in 2024, then tumbled by 126.63% to -$23.2 million in 2025.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at -$23.2 million, -$9.6 million, and -$10.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.